tm logo
Trademark Search
BRISTOL MYERS SQUIBB & DESIGN

View On IC.GC.CA

BRISTOL MYERS SQUIBB & DESIGN
ADVERTISED

on 25 Sep 2024

Last Applicant/ Owned by

BRISTOL-MYERS SQUIBB CANADA CO./LA SOCIÉTÉ BRISTOL-MYERS SQUIBB CANADA

2344 Alfred-Nobel BoulevardSuite 300Montreal

QUEBEC

CA

H4S0A4

Serial Number

2024343 filed on 23rd Apr 2020

Correspondent Address

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

BRISTOL MYERS SQUIBB & DESIGN

Vienna Information

2 . 9 . 14

Hands, folded hands, fingers, handprints or fingerprints, armsMains, mains jointes, doigts, empreintes de mains ou de doigts, bras

2 . 9 . 15

Open hands (palm or back)Mains de face (paume ou revers)

Trademark usage description

pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombos Read More

Classification Information

Class [005]
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as antiinfectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies; pharmaceutical preparations for the treatment of neuropsychiatric disorders; therapeutic radiopharmaceutical preparations for the treatment of cancer and solid tumors; diagnostic radiopharmaceutical preparations; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; radio-isotope markers for therapeutic or diagnostic use; radiopharmaceuticals;

Classification kind code

11

Class [042]
Pharmaceutical research and development services

Classification kind code

11

Class [044]
Medical services, namely, providing information to physicians, health care professionals and patients on the topic of health issues, health awareness and pharmaceuticals; medical services, namely, providing information in the field of healthcare and pharmaceuticals via a website

Classification kind code

11

Mark Details

Serial Number

2024343

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 42
on 25th Sep 2024		Advertised
Submitted for opposition 27
on 29th Aug 2024		Approval Notice Sent
Submitted for opposition 26
on 29th Aug 2024		Approved
Submitted for opposition 22
on 27th Jun 2024		Search Recorded
Submitted for opposition 20
on 27th Jun 2024		Examiner's First Report
Submitted for opposition 287
on 31st Mar 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 23rd Apr 2020		Filed
Submitted for opposition 1
on 23rd Apr 2020		Created
Submitted for opposition 31
on 23rd Apr 2020		Formalized